NASDAQ · Healthcare · Medical Devices
Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Medical Devices & Tools · Donchian | DOWN 100% | Donchian — position within the Donchian channel. DXCM ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · LightGBM | UP 100% | LightGBM — a gradient-boosted model fit on this basket's recent features. DXCM ranks #1 of 10 in Medical Devices & Tools (100% bullish percentile), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Low Volatility | DOWN 100% | Low Volatility — the low-volatility anomaly. DXCM ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile, annualized volatility 40%), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · MACD | DOWN 100% | MACD — MACD histogram momentum crossover. DXCM ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Mean-Reversion | UP 100% | Mean-Reversion — contrarian on the trailing return. DXCM ranks #1 of 10 in Medical Devices & Tools (100% bullish percentile, recent move -10.7%, fading it), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Momentum | DOWN 100% | Momentum — trailing return (trend-following). DXCM ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile, signal -10.5%), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · OBV Trend | DOWN 100% | OBV Trend — on-balance-volume accumulation. DXCM ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Regime Switch | DOWN 100% | Regime Switch — the market looks trending, so it ranked on Momentum. DXCM ranks #4 of 10 in Medical Devices & Tools (100% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · RSI Mean-Reversion | UP 100% | RSI Mean-Reversion — oversold up / overbought down. DXCM ranks #1 of 10 in Medical Devices & Tools (100% bullish percentile, RSI 35), so the agent calls it UP for the next session. |
| Medical Devices & Tools · SOTA Ensemble | UP 100% | SOTA Ensemble — a purged-CV rank ensemble (gradient-boosting + ridge + momentum). DXCM ranks #1 of 10 in Medical Devices & Tools (100% bullish percentile), so the agent calls it UP for the next session. |
| Medical Devices & Tools · 52-Week-High | UP 78% | 52-Week-High — proximity to the trailing high. DXCM ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile, 85% of its 52-week high), so the agent calls it UP for the next session. |
| Medical Devices & Tools · Meta-Ensemble | DOWN 78% | Meta-Ensemble — a blend of this domain's strategies weighted by their recent precision. DXCM ranks #6 of 10 in Medical Devices & Tools (78% bearish percentile), so the agent calls it DOWN for the next session. |
| Medical Devices & Tools · Vol-Adjusted Momentum | UP 78% | Vol-Adjusted Momentum — return per unit of recent volatility. DXCM ranks #3 of 10 in Medical Devices & Tools (78% bullish percentile, return/volatility +0.55), so the agent calls it UP for the next session. |
Best agents on DXCM (graded record)
| Medical Devices & Tools · Dual Momentum | 100% | 1/1 correct | UP |
| Medical Devices & Tools · Relative Strength | 70% | 7/10 correct | UP |
| Medical Devices & Tools · Volume Thrust | 70% | 16/23 correct | UP |
| Medical Devices & Tools · Meta-Ensemble | 57% | 44/77 correct | DOWN |
| Medical Devices & Tools · Long-Term Reversal | 57% | 13/23 correct | UP |
| Medical Devices & Tools · Bollinger Reversion | 56% | 25/45 correct | UP |
| Medical Devices & Tools · Mean-Reversion | 55% | 32/58 correct | UP |
| Medical Devices & Tools · SOTA Ensemble | 55% | 38/69 correct | UP |
| Medical Devices & Tools · Trend Strength | 55% | 45/82 correct | UP |
| Medical Devices & Tools · OBV Trend | 55% | 29/53 correct | DOWN |
Recent news
| 2026-10-22 | Why Is DexCom (DXCM) In Focus After Its G7 Trial Reached NEJM? · yf_tkr_DXCM |
| 2026-10-20 | DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study · yf_tkr_ABT |
| 2026-10-19 | Dexcom EVP Michael Brown sells $145,316 in company stock · investing_com |
| 2026-10-19 | 4 - DEXCOM INC (0001093557) (Issuer) · sec_edgar_current |
| 2026-10-18 | DexCom: The 15-Day Sensor Lowered The Cost Curve Before The Type 2 Wave Arrives · seeking_alpha |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。